October 2015
ITUS Corporation is developing a platform called Cchek™, a series of inexpensive non-invasive blood tests for the early detection of cancer.
February 2016
Christiana Care joins biomarker study
April 2016
Efficacy shown for lung cancer
July 2016
Virtua Healthcare joins biomarker study
September 2016
Efficacy shown for melanoma, colon and ovarian cancers
October 2016
Efficacy shown for liver, thyroid, and pancreatic cancers
November 2016
Efficacy shown for 6 additional cancer types
December 2016
Preliminary cancer patient study results announced
December 2016
MD Anderson Cooper joins biomarker study
In Progress
Latest News & Events
ITUS Corporation Announces First Commercial Focus for Cchek™ will be Prostate Cancer
Read More...ITUS Corporation to Present at the 3rd Annual Disruptive Growth & Healthcare Conference Hosted by RHK Capital and ReedSmith
Read More...ITUS Presentation to Special Meeting of Stockholders
Read More...Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.